Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2019 09:00 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates

RALEIGH, N.C., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and...
February 25, 2019 09:30 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week Conference

RALEIGH, N.C., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and...
February 22, 2019 10:00 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical Officer

RALEIGH, N.C., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...
February 07, 2019 08:34 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference

RALEIGH, N.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT) a clinical stage biotechnology company focused on developing novel autoimmune and inflammation...
December 17, 2018 08:00 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease in 1H 2019 and Announce Top-line NASH Data with Drug Combinations by EASL 2019

Preliminary top-line data from the alcoholic steatohepatitis (ASH) collaboration with Massachusetts General Hospital shows positive effect of larazotide on ethanol-induced permeability in vitro ...
December 04, 2018 11:15 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Enters into a Collaboration with Massachusetts General Hospital and Announces Capital Update for the Celiac Disease Clinical Program and its NASH Development Strategy on December 17, 2018

-- Announces collaboration in high unmet need Alcoholic Liver Diseases (ALD), including severe alcoholic hepatitis, with novel gut-specific, clinical-stage asset, larazotide acetate-- Investor update...
November 26, 2018 06:00 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Strengthens Clinical Development with the Addition of Patrick H. Griffin, M.D., F.A.C.P.

RALEIGH, N.C., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical-stage biotechnology company focused on developing novel medicines for autoimmune and...
November 13, 2018 17:26 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Reports Third Quarter 2018 Earnings and Key Corporate Highlights

Poster presentation at the American Association of Study of Liver Diseases showing promising pre-clinical data of larazotide acetate in NASH reducing intestinal permeability. Innovate plans to...
November 12, 2018 08:10 ET | Source: Innovate Biopharmaceuticals, Inc

Sanyal Biotechnology and Innovate Biopharmaceuticals Present Data at AASLD Validating a Proprietary “Leaky Gut” Assay Demonstrating Reduced Intestinal Permeability with Larazotide Acetate Treatment in a NASH Preclinical Study

Significant effect on gut epithelial integrity, a mechanism thought to be key for bacterial translocation leading to NAFLD and NASH. Innovate plans to launch a clinical development program for NASH in...
November 05, 2018 09:15 ET | Source: Innovate Biopharmaceuticals, Inc

Innovate Biopharmaceuticals Announces Presentation at the BIO-Europe Conference, Copenhagen 2018 - 24th Annual Partnering Conference

RALEIGH, N.C., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Innovate) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...